Karen Yanson (United States of America)
BD Life Sciences Diagnostic Systems
Presenter of 1 Presentation
A PRIMARY HUMAN PAPILLOMAVIRUS ALGORITHM WITH INTEGRATED 16/18 GENOTYPING USING THE ONCLARITY ASSAY FOR CERVICAL CANCER SCREENING: BASELINE AND THREE-YEAR TRIAL RESULTS (ID 847)
Session Time
11:35 - 12:50
Session Type
Clinical Science Oral Session
Lecture Time
11:47 - 11:59
[{"name":"A PRIMARY HUMAN PAPILLOMAVIRUS ALGORITHM WITH INTEGRATED 16\/18 GENOTYPING USING THE ONCLARITY ASSAY FOR CERVICAL CANCER SCREENING: BASELINE AND THREE-YEAR TRIAL RESULTS \u003Csmall\u003E(ID 847)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":847,"presentation":"A PRIMARY HUMAN PAPILLOMAVIRUS ALGORITHM WITH INTEGRATED 16\/18 GENOTYPING USING THE ONCLARITY ASSAY FOR CERVICAL CANCER SCREENING: BASELINE AND THREE-YEAR TRIAL RESULTS \u003Csmall\u003E(ID 847)\u003C\/small\u003E","session":"Oral Session 5: Vaccines and Screening in HPV-related disease","presenter":"Karen Yanson (United States of America)","photo":""},"playlist":[{"name":"A PRIMARY HUMAN PAPILLOMAVIRUS ALGORITHM WITH INTEGRATED 16\/18 GENOTYPING USING THE ONCLARITY ASSAY ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/130\/GMT20200611-155415_Karen-Yans_as_1920x1080-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/130\/GMT20200611-155415_Karen-Yans_as_1920x1080-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/130\/DE86AC5A.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/130\/GMT20200611-155415_Karen-Yans_as_1920x1080-0.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22UU0fB"}
[session]
[presentation]
[presenter]
